JNJ

Johnson & Johnson NYSE

Healthcare ·Drug Manufacturers - General ·US · jnj.com

$224.20

After hrs $226.00 +0.18%

Mkt Cap $539.7B

52w Low $146.12 73.9% of range 52w High $251.71

50d MA $238.51 200d MA $206.27

P/E (TTM) 20.6x

EV/EBITDA 13.0x

P/B 6.8x

Debt/Equity 0.6x

ROE 25.9%

P/FCF 25.6x

RSI (14) —

ATR (14) —

Beta 0.33

50d MA $238.51

200d MA $206.27

Avg Volume 8.3M

About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 14, 2026	AMC	2.68	2.70	+0.7%	240.10	-0.1%	-0.6%	-2.3%	-2.5%	-3.9%	-5.8%	—
Jan 21, 2026	AMC	2.46	2.46	+0.0%	218.01	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%	—
Oct 14, 2025	AMC	2.76	2.80	+1.4%	190.85	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%	—
Jul 16, 2025	AMC	2.68	2.77	+3.4%	164.78	-1.0%	-1.1%	-0.7%	-0.3%	+1.9%	+2.6%	—
Apr 15, 2025	AMC	2.58	2.77	+7.4%	153.62	+1.1%	+0.2%	+2.5%	+2.1%	+2.7%	+1.1%	—
Jan 22, 2025	AMC	1.99	2.04	+2.5%	145.27	+0.1%	+0.9%	+1.1%	+5.3%	+3.5%	+4.0%	—
Oct 15, 2024	AMC	2.21	2.42	+9.5%	164.10	-0.1%	+0.1%	+0.2%	+0.6%	-0.8%	-0.4%	—
Jul 17, 2024	AMC	2.71	2.82	+4.1%	156.58	-0.6%	-0.7%	-1.2%	-1.5%	-2.7%	-0.2%	—
Apr 16, 2024	AMC	2.64	2.71	+2.7%	144.45	+0.4%	+0.2%	+0.9%	+2.4%	+3.2%	+3.5%	—
Jan 23, 2024	AMC	2.27	2.29	+0.9%	159.81	-0.0%	-0.5%	-0.2%	-0.2%	-0.3%	-0.7%	—
Oct 17, 2023	AMC	2.52	2.66	+5.6%	156.09	-0.4%	-2.2%	-2.4%	-2.0%	-3.0%	-3.1%	—
Jul 20, 2023	AMC	2.61	2.80	+7.3%	168.38	-0.1%	+1.1%	+1.6%	+2.4%	+2.6%	+3.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Barclays	Maintains	Equal Weight → Equal Weight	—	$240.10	$239.94	-0.1%	-0.6%	-2.3%	-2.5%	-3.9%	-5.8%
Apr 15	Wells Fargo	Maintains	Overweight → Overweight	—	$240.10	$239.94	-0.1%	-0.6%	-2.3%	-2.5%	-3.9%	-5.8%
Apr 15	Stifel	Maintains	Hold → Hold	—	$240.10	$239.94	-0.1%	-0.6%	-2.3%	-2.5%	-3.9%	-5.8%
Apr 10	Morgan Stanley	Maintains	Overweight → Overweight	—	$241.31	$242.00	+0.3%	-1.2%	-1.4%	-0.5%	-1.1%	-2.8%
Mar 30	RBC Capital	Maintains	Outperform → Outperform	—	$240.45	$243.49	+1.3%	+0.8%	+1.7%	+1.5%	+1.1%	+0.2%
Mar 19	Barclays	Maintains	Equal Weight → Equal Weight	—	$237.28	$238.34	+0.4%	+0.1%	-0.8%	-0.8%	-0.8%	+1.1%
Mar 17	HSBC	Maintains	Buy → Buy	—	$243.19	$243.58	+0.2%	-2.1%	-2.4%	-2.3%	-3.2%	-3.2%
Mar 11	Citigroup	Maintains	Buy → Buy	—	$243.71	$242.87	-0.3%	-0.3%	-0.7%	-0.9%	-0.2%	-2.3%
Mar 5	JP Morgan	Maintains	Neutral → Neutral	—	$245.30	$242.63	-1.1%	-2.3%	-2.0%	-1.1%	-0.6%	-0.9%
Feb 3	RBC Capital	Maintains	Outperform → Outperform	—	$230.75	$231.50	+0.3%	+1.0%	+1.6%	+3.1%	+4.0%	+3.4%
Jan 28	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$224.44	$226.40	+0.9%	+1.5%	+1.3%	+1.3%	+2.8%	+3.9%
Jan 27	Freedom Capital Markets	Maintains	Hold → Hold	—	$221.49	$222.00	+0.2%	+1.3%	+2.8%	+2.6%	+2.6%	+4.2%
Jan 27	Freedom Broker	Maintains	Hold → Hold	—	$221.49	$222.00	+0.2%	+1.3%	+2.8%	+2.6%	+2.6%	+4.2%
Jan 23	Guggenheim	Maintains	Buy → Buy	—	$218.49	$219.80	+0.6%	+0.8%	+1.4%	+2.7%	+4.2%	+4.0%
Jan 22	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	Wells Fargo	Maintains	Overweight → Overweight	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	Citigroup	Maintains	Buy → Buy	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	TD Cowen	Maintains	Buy → Buy	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	BofA Securities	Maintains	Neutral → Neutral	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	Stifel	Maintains	Hold → Hold	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 22	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$218.01	$218.77	+0.3%	+0.2%	+1.0%	+1.6%	+2.9%	+4.5%
Jan 9	Bernstein	Maintains	Market Perform → Market Perform	—	$205.75	$205.91	+0.1%	-0.7%	+1.9%	+3.8%	+6.2%	+6.7%
Dec 30	Barclays	Maintains	Equal Weight → Equal Weight	—	$207.56	$207.51	-0.0%	-0.3%	-0.3%	-0.1%	-1.6%	-1.3%
Dec 19	Goldman Sachs	Maintains	Buy → Buy	—	$208.31	$207.56	-0.4%	-0.9%	-0.5%	-1.2%	-0.3%	-0.3%
Dec 15	BofA Securities	Maintains	Neutral → Neutral	—	$211.58	$210.35	-0.6%	+1.2%	-1.1%	-0.6%	-1.5%	-2.5%
Dec 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$210.01	$210.28	+0.1%	+0.7%	+2.0%	-0.3%	+0.2%	-0.8%
Dec 11	RBC Capital	Maintains	Outperform → Outperform	—	$206.54	$207.90	+0.7%	+1.7%	+2.4%	+3.7%	+1.3%	+1.8%
Dec 11	Citigroup	Maintains	Buy → Buy	—	$206.54	$207.90	+0.7%	+1.7%	+2.4%	+3.7%	+1.3%	+1.8%
Dec 5	Guggenheim	Maintains	Buy → Buy	—	$202.48	$202.98	+0.2%	-0.3%	-0.4%	-1.2%	+2.0%	+3.7%
Dec 2	Barclays	Maintains	Equal Weight → Equal Weight	—	$205.34	$205.24	-0.0%	+0.0%	-0.0%	-1.4%	-1.7%	-1.8%
Oct 22	Freedom Capital Markets	Downgrade	Buy → Hold	—	$191.88	$192.00	+0.1%	+0.6%	+0.3%	-0.8%	-0.8%	-2.6%
Oct 22	Freedom Broker	Downgrade	Buy → Hold	—	$191.88	$192.00	+0.1%	+0.6%	+0.3%	-0.8%	-0.8%	-2.6%
Oct 15	Raymond James	Maintains	Outperform → Outperform	—	$190.85	$191.48	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%
Oct 15	BofA Securities	Maintains	Neutral → Neutral	—	$190.85	$191.48	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%
Oct 15	Citigroup	Maintains	Buy → Buy	—	$190.85	$191.48	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%
Oct 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$190.85	$191.48	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%
Oct 15	Stifel	Maintains	Hold → Hold	—	$190.85	$191.48	+0.3%	+0.2%	+0.7%	+1.2%	+1.5%	+0.5%
Oct 14	UBS	Maintains	Buy → Buy	—	$190.90	$192.92	+1.1%	-0.0%	+0.1%	+0.6%	+1.2%	+1.5%
Oct 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$191.08	$192.01	+0.5%	-0.2%	-0.1%	-0.1%	+0.0%	+0.5%
Oct 9	Goldman Sachs	Maintains	Buy → Buy	—	$189.69	$190.00	+0.2%	+0.7%	+0.5%	+0.6%	+0.6%	+0.8%
Oct 7	Citigroup	Maintains	Buy → Buy	—	$188.16	$183.77	-2.3%	+0.4%	+0.8%	+1.6%	+1.4%	+1.5%
Oct 6	Bernstein	Maintains	Market Perform → Market Perform	—	$188.64	$188.00	-0.3%	-0.3%	+0.1%	+0.6%	+1.3%	+1.1%
Oct 3	BofA Securities	Maintains	Neutral → Neutral	—	$185.98	$187.06	+0.6%	+1.4%	+1.2%	+1.6%	+2.0%	+2.7%
Oct 3	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$185.98	$187.06	+0.6%	+1.4%	+1.2%	+1.6%	+2.0%	+2.7%
Sep 23	Guggenheim	Upgrade	Neutral → Buy	—	$174.21	$174.89	+0.4%	+1.4%	+1.4%	+2.0%	+3.2%	+4.3%
Sep 16	JP Morgan	Maintains	Neutral → Neutral	—	$177.40	$177.57	+0.1%	-0.5%	-0.1%	-1.8%	-0.7%	-1.8%
Aug 21	Citigroup	Maintains	Buy → Buy	—	$178.84	$178.55	-0.2%	+0.1%	+0.3%	-0.2%	-1.3%	-1.1%
Jul 17	Guggenheim	Maintains	Neutral → Neutral	—	$164.78	$163.18	-1.0%	-1.1%	-0.7%	-0.3%	+1.9%	+2.6%
Jul 17	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$164.78	$163.18	-1.0%	-1.1%	-0.7%	-0.3%	+1.9%	+2.6%
Jul 17	BofA Securities	Maintains	Neutral → Neutral	—	$164.78	$163.18	-1.0%	-1.1%	-0.7%	-0.3%	+1.9%	+2.6%

Recent Filings

8-K

Johnson & Johnson -- 8-K Filing

Johnson & Johnson shareholders rejected a proposal requiring an independent board chair while reelecting their auditor, maintaining current governance structure.

Apr 28

Cramer's Stop Trading: Johnson & Johnson

Apr 24

Jim Cramer explains why he is wary of chasing 'parabolic' stocks

Apr 20

8-K · 8.01 !! High

Unknown — 8-K 8.01: Material Event / Announcement

Johnson & Johnson reported Q1 2026 earnings on April 14, 2026; investors should review the detailed financial results and sales data to assess whether the company met expectations and maintained growth momentum.

Apr 14

Data updated apr 24, 2026 9:57am · Source: massive.com